retatrutide phase 3 trial just delivered the most powerful weight loss data ever recorded in a obesity trial. At 104 weeks, participants on the 12 mg dose lost an average of 85 pounds Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $5.55 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14























